IFLR1000

Advent International €1.9 billion acquisition of Zentiva from Sanofi

1/10/2018
Private acquisition
Select tab

€ 1.9 billion

$ 2.096 billion

Completed

1/10/2018

Overview:

  • Advent International has acquired Zentiva, the European generics business of Sanofi for €1.9 billion.

Laura Mendes - Researcher

Jurisdiction:

France

Deal type:

Private acquisition

Practice area:

M&A

Governing law:

France

Industry sector:

Healthcare

Firms:
Allen & Overy

Party: Zentiva (Target)

Lawyers: Marc Castagnède, Romy Richter

Freshfields Bruckhaus Deringer

Party: Advent International (Acquirer)

Weil Gotshal & Manges

Party: Sanofi (Seller)

Related deals